Table 2.
Abnormal metabolism associated with autism spectrum disorder from metabolomic studies in blood samples
| Ref and Subjects | Age (years) | Method | Categories of Metabo- lites/ Involved metabolic pathways |
Changes in metabolites compared to typical children |
Interpretation | |
|---|---|---|---|---|---|---|
| Increase | Decrease | |||||
| Kelly et al. 2019 | ||||||
| 403 children (365 categorized to “on schedule” and 38 categorized to “requiring further monitoring/evaluation” from ASQ) | 3 | Targeted approach using UPLC-MS/MS | Tyrosine metabolism | N-formylphenylalanine | There are abnormalities of amino acid (tyrosine, tryptophan, arginine, proline, methionine, cysteine, and taurine), lipid (phospholipid, sphingolipid, and fatty acid), urea cycle, and xenobiotics metabolism in children with poor ASQ communication skills, relative to children with typical communication development. | |
| Phospholipid metabolism | trimethylamine N-oxide | |||||
| Food Component/Plant | Cinnamoylglycine Erythritol |
Pyrraline | ||||
| Endocannabinoid | Oleoyl ethanolamide Palmitoyl ethanolamide Linoleoyl ethanolamide |
|||||
| Tryptophan metabolism | Serotonin | 5-hydroxyindoleacetate N-formylanthranilic acid |
||||
| Sphingolipid metabolism | Sphingomyelin | |||||
| Fatty acid metabolism | Docosahexaenoylcarnitine | |||||
| Urea cycle | Prolylhydroxyproline | |||||
| Arginine and Proline metabolism | Prolylhydroxyproline | |||||
| Methionine, cysteine, and Taurine metabolism | Alpha-ketobutyrate | |||||
| Smith et al. 2019 | ||||||
| 516 ASD compared with 164 typical children | 1.5-4 | Targeted approach using LC-MS | BCAA metabolism | Glutamine-to-isoleucine ratio Glutamine-to-leucine ratio Glutamine-to-valine ratio Glycine-to-isoleucine ratio Glycine-to-leucine ratio Glycine-to-valine ratio Ornithine-to-isoleucine Ornithine-to-leucine ratio Ornithine-to-valine ratio |
There are abnormalities of BCAA metabolism in plasma of ASD. | |
| Rangel-Huerta et al. 2019 | ||||||
| 30 ASD compared with 30 typical children | 2-6 | Untargeted approach using LC-MS | Neurotransmitter | Glutamate | There are abnormalities of neurotransmitter, reactive oxidative stress, BCAA, NAD, phospholipid metabolism in plasma of ASD. | |
| Reactive oxidative stress | Arginine N-acetylarginine Homoarginine |
|||||
| BCAA metabolism | 3-methyl-2-oxobutyrate 3-methyl-2-oxovalerate 4-methyl-2-oxopentanoate Isovalerylcarnitine Isobutyrylcarnitine |
|||||
| NAD+ metabolism | 1-methylnicotinamide N-methyl-2-pyridone-5-carboxamide |
Nicotinamide | ||||
| Phospholipid metabolism | 1-palmitoyl-glycerol-phosphatidyl-etholamine 1-stearoyl-glycerol-phosphatidyl-etholamine |
|||||
| Others | n-alpha-acetylornithine Tryptophan Kynurenine 5-bromotryptophan 3-indoxyl sulfate Indole lactate 6-hydroxyindole sulfate |
|||||
| Orozco et al. 2019 | ||||||
| 167 ASD 51 i-DD 31 DS 193 typical children | 2-5 | Untargeted approach using 1H-NMR | One carbon metabolism | Glycine Serine |
There are abnormalities of one carbon metabolism, TCA cycle, urea cycle in plasma of ASD. | |
| TCA cycle | Cis-aconitate | |||||
| Urea cycle | Ornithine | |||||
| Lv et al. 2018 | ||||||
| 60 ASD compared with 30 typical children | 2-5 | Targeted approach using MS/MS | Fatty acid metabolism | Free carnitine Glutaryl carnitine Octyl carnitine Twenty-four carbonyl carnitine Carnosyl carnitine |
There are abnormalities of fatty acid metabolism (free carnitine, short and long chain acyl carnitines) in plasma of ASD. | |
| Anwar et al. 2018 | ||||||
| 38 ASD compared with 31 typical children | 5-12 | Targeted approach using LC-MS | Protein glycation | Nε-carboxymethyllysine Nω-carboxymethyllysine |
3-deoxyglucoosone-derived hydroimidazolone | There are abnormalities of protein glycation and protein oxidation metabolism in plasma of ASD. |
| Protein oxidation | Dityrosine | |||||
| Wang et al. 2016 | ||||||
| 173 ASD compared with 163 typical children | 3-6 | Untargeted approach using UPLC/Q-TOF MS/MS | Fatty acid metabolism | Docosahexaenoic acid Docosapentaenoic acid |
There are abnormalities of fatty acid, sphingomyelin, lysophosphatide, and beta oxidation in plasma of ASD. | |
| Sphingomyelin metabolism | Sphingosine-1-phosphate | |||||
| Lysophosphatide metabolism | LPA LysoPE |
|||||
| Fatty acid beta oxidation | Decanoylcarnitine | 9,10-Epoxyoctadecenoic acid | ||||
| Others | Pregnanetriol | Adrenic acid Uric acid |
||||
| West et al. 2014 | ||||||
| 52 ASD compared with 30 typical children | 4-6 | Targeted approach using GC-MS and untargeted approach using LC-HRMS | TCA cycle | Succinate | Citrate | There are abnormalities of TCA cycle, fatty acid, oxidative phosphorylation, mitochondrial dysfunction, and gut microbiome metabolism in plasma of ASD. |
| Fatty acid metabolism and oxidative stress | Methylhexa-decanoic acid Hepta-decanoic acid |
|||||
| Oxidative phosphorylation | Aspartate Glutamate |
|||||
| Mitochondrial energy production | DHEA-S | Isoleucine | ||||
| Gut microbiome | 4-hydroxyphenyllactate | |||||
| Others | Glutaric acid 3-aminoisobutyric acid |
Creatinine Homocitrulline |
||||
| Kuwabara et al. 2013 | ||||||
| 25 ASD compared with 28 typical children | 25-40 male | Untargeted approach using CE-TOF-MS | Oxidative stress | Arginine Taurine |
5-Oxoproline | There are abnormalities of oxidative stress and mitochondrial metabolism in plasma of ASD. |
| Mitochondrial dysfunction | Lactic acid | |||||
| Delaye et al. 2018 | ||||||
| 22 ASD 29 ID 30 typical children | > 18 | Targeted approach using amino acid chromatography | Neurotransmitter | Glutamate Serine |
There are abnormalities of neurotransmitter metabolism in plasma of ASD. | |
| Others | Proline Ornithine |
|||||
ASD autism spectrum disorder, i-DD idiopathic-developmental delay, DS Down syndrome, ID intellectual disability, ASQ Ages and Stages Questionnaire, UPLC-MS/MS ultra-performance liquid chromatography-tandem mass spectrometer, LC–MS liquid chromatography–mass spectrometry, GC–MS gas chromatography-mass spectrometry, 1H-NMR hydrogen-1 nuclear magnetic resonance, MS/MS tandem mass spectrometry, UPLC/Q-TOF–MS ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry, LC-HRMS liquid chromatography-high resolution mass spectrometry, CE-TOF–MS capillary-electrophoresis-time-of-flight-mass-spectrometer, NAD nicotinamide adenine dinucleotide, LPA lysophosphatidic acid, LysoPE lysophosphatidylethanolamine, BCAA branched-chain amino acids, TCA tricarboxylic acid cycle, DHEA-S dehydroepiandrosterone sulfate